IL110376A - Pharmaceutical preparations containing iftroban and methods for their preparation - Google Patents

Pharmaceutical preparations containing iftroban and methods for their preparation

Info

Publication number
IL110376A
IL110376A IL11037694A IL11037694A IL110376A IL 110376 A IL110376 A IL 110376A IL 11037694 A IL11037694 A IL 11037694A IL 11037694 A IL11037694 A IL 11037694A IL 110376 A IL110376 A IL 110376A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
salt
ifetroban
weight
cellulose
Prior art date
Application number
IL11037694A
Other languages
English (en)
Hebrew (he)
Other versions
IL110376A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL110376A0 publication Critical patent/IL110376A0/xx
Publication of IL110376A publication Critical patent/IL110376A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11037694A 1993-08-02 1994-07-19 Pharmaceutical preparations containing iftroban and methods for their preparation IL110376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10080293A 1993-08-02 1993-08-02

Publications (2)

Publication Number Publication Date
IL110376A0 IL110376A0 (en) 1994-10-21
IL110376A true IL110376A (en) 1998-08-16

Family

ID=22281616

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11037694A IL110376A (en) 1993-08-02 1994-07-19 Pharmaceutical preparations containing iftroban and methods for their preparation

Country Status (15)

Country Link
EP (1) EP0638310A1 (zh)
JP (1) JPH07145052A (zh)
KR (1) KR950005309A (zh)
CN (1) CN1118254A (zh)
AU (1) AU6878294A (zh)
CA (1) CA2129099A1 (zh)
CZ (1) CZ181094A3 (zh)
FI (1) FI943569A (zh)
HU (1) HUT70951A (zh)
IL (1) IL110376A (zh)
NO (1) NO942854L (zh)
NZ (1) NZ264129A (zh)
PL (1) PL304508A1 (zh)
RU (1) RU94028273A (zh)
ZA (1) ZA945672B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US6328994B1 (en) 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
TWI257311B (en) 1998-07-28 2006-07-01 Takeda Chemical Industries Ltd Rapidly disintegrable solid preparation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP4698000B2 (ja) * 2000-06-27 2011-06-08 旭化成ケミカルズ株式会社 水易溶性薬物含有錠剤
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
JP3841804B2 (ja) * 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
DK2049123T4 (en) 2006-08-03 2016-11-28 Horizon Pharma Ag LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
HUE035990T2 (en) 2007-03-29 2018-05-28 Daiichi Sankyo Co Ltd Pharmaceutical preparation
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
ES2848348T3 (es) 2014-05-16 2021-08-06 Cumberland Pharmaceuticals Inc Composiciones y métodos de tratamiento con ifetroban de la fibrosis cardíaca
KR102448406B1 (ko) 2015-06-30 2022-09-27 큠버랜드 파마슈티컬즈 인코포레이티드 Ａｅｒｄ/천식에서 트롬복산 수용체 길항제
JP2019519487A (ja) 2016-05-05 2019-07-11 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
AU2017263462B2 (en) 2016-05-11 2021-05-13 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
DD299186A5 (de) * 1990-10-01 1992-04-02 E.R. Squibb U. Sons,Inc.,Us Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga

Also Published As

Publication number Publication date
PL304508A1 (en) 1995-02-06
KR950005309A (ko) 1995-03-20
EP0638310A1 (en) 1995-02-15
IL110376A0 (en) 1994-10-21
RU94028273A (ru) 1996-11-10
FI943569A (fi) 1995-02-03
CN1118254A (zh) 1996-03-13
FI943569A0 (fi) 1994-07-29
NO942854D0 (zh) 1994-08-01
AU6878294A (en) 1995-02-09
HU9402254D0 (en) 1994-09-28
NO942854L (no) 1995-02-03
JPH07145052A (ja) 1995-06-06
HUT70951A (en) 1995-11-28
ZA945672B (en) 1995-03-06
CZ181094A3 (en) 1995-02-15
CA2129099A1 (en) 1995-02-03
NZ264129A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
US5506248A (en) Pharmaceutical compositions having good dissolution properties
IL110376A (en) Pharmaceutical preparations containing iftroban and methods for their preparation
US5030447A (en) Pharmaceutical compositions having good stability
US5180589A (en) Pravastatin pharmaceuatical compositions having good stability
US6174548B1 (en) Omeprazole formulation
KR0179343B1 (ko) 속용성 고형 제제
AU2005320609B9 (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
AU658209B2 (en) Pharmaceutical combination formulation
WO1992022284A1 (de) Pantoprazol enthaltende orale darreichungsformen
JPH0768125B2 (ja) 酸不安定化合物の内服用製剤
EP0910344A1 (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US20070224260A1 (en) Dosage Form Having Polymorphic Stability
IE861671L (en) Stable solid dosage forms with elastic film coating
WO2008027600A2 (en) Imatinib compositions
JP4127740B2 (ja) 安定化したベンズイミダゾール系化合物含有組成物
PT2468361E (pt) Formulações de vildagliptina
JPH0157090B2 (zh)
EP3764983B1 (en) A sustained release formulation comprising acemetacin with bimodal in vitro release
WO2008053295A2 (en) Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid
EP3185856A1 (en) Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
JP2935220B6 (ja) 安定性良好な医薬組成物
KR0142435B1 (ko) 양호한 안정성을 갖는 제약 조성물

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void